Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
Table 1
Baseline clinical characteristics of 21 patients with LDL apheresis.
Age, years
Female
3 (14.3%)
BMI, kg/m2
Hypertension
11 (52%)
Diabetes
4 (19%)
Smoking
5 (24%)
Previous conditions
Myocardial infarction
6 (29%)
Coronary artery bypass grafting
10 (48%)
PCI angioplasty
5 (24%)
Medications
Beta-blockers
12 (57%)
ACE inhibitors
0 (0%)
Nitrates
2 (10%)
Calcium-channel blockers
6 (56%)
Statins
19 (90%)
Fibrates
7 (33%)
Colesevelam
14 (67%)
Ezetimibe
10 (48%)
Aspirin
10 (48%)
Clopidogrel
5 (24%)
Acenocoumarin
2 (10%)
LDL apheresis period, months
LDL cholesterol before entry
mmol/l ( mg/dL)
LDL indicates low-density lipoprotein, PCI indicates percutaneous coronary intervention, and ACE indicates angiotensin-converting enzyme. Values were expressed as means ± standard deviation (SD); other values were numbers of patients with percentages given in parentheses.